Clinical Trials Browser

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07551050 2026-04-24

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Recruiting

300 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06681064 2026-04-16

BELIEVE

Recruiting

500 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05404321 2026-03-19

TRIPLEX

Recruiting

163 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07084571 2026-03-12

FORTITUDE

Recruiting

200 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06709651 2026-03-04

MINA

Recruiting

30 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

Recruiting

900 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT05914961 2026-02-12

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

Recruiting

225 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07327489 2026-01-08

ELEPHAS-05

Recruiting

2,000 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06774027 2025-12-18

ENCORE

Recruiting

100 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07260188 2025-12-03

PDO-Neo01

Recruiting

240 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02302742 2025-10-06

PROGECT

Recruiting

1,500 enrolled

BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome, Triple Negative Breast Neoplasms

NCT06087120 2025-09-23

BRAVA

Recruiting

125 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07073755 2025-07-18

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Recruiting

200 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05396612 2025-07-08

Role of the Immune Environment in Response to Therapy in Breast Cancer

Recruiting

300 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06991790 2025-05-28

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Recruiting

51 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06476119 2025-04-23

OPTImaL

Recruiting

490 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04510129 2025-03-12

A Multicenter Cancer Biospecimen Collection Study

Recruiting

1,650 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06230185 2025-01-07